Leukemia With IKZF₁ Deletion Benefits From Prolonged Maintenance Therapy
Prolonged maintenance therapy for IKZF₁del improved five-year cumulative risk for relapse and event-free survival
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.